R&T Forum – ‘Precision’ Medicine and Environments: Emerging Opportunities for Individualized Care and Comfort

SyracuseCoE and Central New York Biotechnology Accelerator (CNY BAC) partnered in a joint Research and Technology Forum yesterday that explored emerging approaches at the interface of health care and environmental control. The Forum included presentations by Dr. Robert Corona, SUNY Upstate Vice President for Innovation and Business Development, and Mike Wetzel, President and CEO of Air Innovations. The presenters offered insight about how to utilize precision medicine to customize healthcare and to take into account the biological, environmental and behavioral factors that drive disease.

Right from the start, many SyracuseCoE partners have pursued a vision for leveraging one of Central New York’s signature industry clusters to catalyze innovations in technologies for built environments that would improve occupant health and wellness. Synergistically, the Central New York Biotechnology Accelerator (CNY BAC) envisions building on regional strengths to advance innovations in precision medicine.


Dr. Robert Corona, DO, MBA, FCAP, FASCP, John B, Henry and Chair of Pathology, Medical Director of Neuropathology/Pathology, Vice President for Innovation and Business Development, Central New York Biotech Accelerator, Upstate Medical University

Mike Wetzel, President and CEO, Management Board of Directors, Air Innovations


Ed Bogucz, Executive Director, SyracuseCoE, Associate Professor, Syracuse University’s College of Engineering and Computer Science, Department of Mechanical and Aerospace Engineering